The HLA-DR phenotype modulates the humoral immune response to enterovirus antigens

Diabetologia

Volumn 46, Issue 8, 2003, Pages 1100-1105

  Sadeharju, K ^a,e   Knip, M ^b,c,e   Hiltunen, M ^d   Akerblom H K ^c   Hyoty H ^a,b,e  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d ACADEMY OF FINLAND   (Finland)

^e Juvenile Diabetes Research Foundation International   (United States)

Author keywords

Enterovirus; HLA DR; Immune response; Mumps; Type 1 diabetes; Vaccine

Indexed keywords

HLA DR2 ANTIGEN; HLA DR3 ANTIGEN; HLA DR4 ANTIGEN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; MEASLES MUMPS RUBELLA VACCINE; POLIOMYELITIS VACCINE; VIRUS ANTIBODY; VIRUS ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; COXSACKIE VIRUS B4; ENTEROVIRUS INFECTION; FEMALE; FINLAND; GENETIC SUSCEPTIBILITY; HLA TYPING; HUMAN; HUMORAL IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MUMPS VIRUS; POLIOMYELITIS VIRUS 1; PRIORITY JOURNAL; RISK FACTOR; SIBLING; VIRUS CELL INTERACTION;

EID: 0042378820     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-003-1157-x     Document Type: Article

References (24)

1. D'Alessio DJ (1992) A case-control study of group B coxsackievirus immunoglobulin M antibody prevalence and HLA-DR antigens in newly diagnosed cases of insulin-dependent diabetes mellitus. Am J Epidemiol 135:1331-1338
2. Lönnrot M, Korpela K, Knip M et al. (2000) Enterovirus infection as a risk factor for beta-cell autoimmunity in the prospective birth-cohort trial DIPP. Diabetes 49:1314-1318
3. Hyöty H (2002) Enterovirus infections and type 1 diabetes. Ann Med 34:138-147
4. Svejgaard A, Platz P, Ryder LP (1983) HLA and disease 1982 - a survey. Immunol Rev 70:193-218
5. Ilonen J, Herva E, Tiilikainen A et al. (1978) HLA-Dw2 as a marker of resistance against juvenile diabetes mellitus. Tissue Antigens 11:144-146
6. Bruserud O, Jervell J, Thorsby E (1985) HLA-DR 3 and -DR4 control T-lymphocyte responses to mumps and Coxsackie B4 virus: studies on patients with type 1 (insulin-dependent) diabetes and healthy subjects. Diabetologia 28:420-426
7. Schernthaner G, Banatvala JE, Scherbaum W et al. (1985) Coxsackie-B-virus-specific IgM responses, complement-fixing islet-cell antibodies, HLA DR antigens and C-peptide secretion in insulin-dependent diabetes mellitus. Lancet 9:630-632
8. Tuomilehto J, Lounamaa R, Tuomilehto-Wolf E et al. (1992) Epidemiology of childhood diabetes mellitus in Finland - background of a nationwide study of type 1 (insulin-dependent) diabetes mellitus. Diabetologia 35:70-76
9. Peltola H, Karanko V, Kurki T et al. (1986) Rapid effect on endemic measles, mumps and rubella of nationwide vaccination programme in Finland. Lancet I:137-139
10. Paunio M (1988) Compliance and vaccination coverage. Health Services Research by the National Board of Health in Finland, Helsinki, no 47 (Thesis)
11. Hyoty H, Huupponen T, Leinikki P (1985) Humoral immunity against viral antigens in insulin-dependent diabetes mellitus (IDDM): altered IgA class immune response against mumps virus. Clin Exp Immunol 60:139-144
12. Julkunen I. Hautanen A. Keski-Oja J (1983) Interaction of viral envelope glycoproteins with fibronectin. Infect Immun 40:876-881
13. Samuelson A, Glimåker M, Skoog E, Cello J, Forsgren M (1993) Diagnosis of enteroviral meningitis with IgG-EIA using heat-treated virions and synthetic peptides as antigens. J Med Virol 40:271-277
14. Hyöty H, Hiltunen M, Knip M et al. (1995) A prospective study of the role of Coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Diabetes 44:652-657
15. Tuomilehto-Wolf E, Tuomilehto J, Cepaitis Z, Lounamaa R (1989) New susceptibility haplotype for type 1 diabetes. DIME Study Group. Lancet ii:299-302
16. Bruserud O,Thorsby E (1985) HLA control of the proliferative T lymphocyte response to antigenic determinants on mumps virus: studies on healthy individuals and patients with type 1 diabetes. Scand J Immunol 22:509-518
17. Troye-Blomberg M (2002) Genetic regulation of malaria infection in humans. Chem Immunol 80:243-252
18. Al Jabri AA (2002) HLA and in vitro susceptibility to HIV infection. Mol Immunol 38:959-967
19. Hue S, Cacoub P, Renou C et al. (2002) Human leukocyte antigen class II alleles may contribute to the severity of hepatitis C virus-related liver disease. J Inf Dis 186:106-109
20. Bertoletti A, Ferrari C, Fiaccadori F (1996) Role of the cell-mediated immune response in the pathogenesis of hepatitis B virus infection: possible immune-therapeutic strategies. Acta Biomed Ateneo Parmense 67:87-93
21. Konya J, Dillner J (2001) Immunity to oncogenic human papillomaviruses. Adv Cancer Res 82:205-238
22. Mustonen J, Partanen J, Kanerva M et al. (1998) Association of HLA B27 with benign clinical course of nephropathia epidemica caused by Puumala hantavirus. Scand J Immunol 47:277-279
23. Morens D, Pallansch MA (1995) Epidemiology. In: Rotbart HA (ed.) Human enterovirus infections. ASM Press, Washington, pp 3-23
24. Karvonen M, Viik-Kajander M, Moltchanova E, Libman I, LaPorte R and Tuomilehto J (2000) Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group. Diabetes Care 23:1516-1526